Free Trial

Delcath Systems (DCTH) Insider Trading & Ownership

Delcath Systems logo
$9.39 +0.16 (+1.73%)
(As of 11/15/2024 ET)

Delcath Systems (NASDAQ:DCTH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.94%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$512,861.04
Number Of
Insiders Selling
(Last 12 Months)
0
Get DCTH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Delcath Systems stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DCTH Insider Buying and Selling by Quarter

Delcath Systems Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/19/2024Gil AharonDirectorBuy26,882$3.72$100,001.04  
12/8/2023Gerard J MichelCEOBuy34,000$2.94$99,960.00  
11/17/2023Rosalind Advisors, Inc.DirectorBuy100,000$2.40$240,000.00  
11/17/2023Sandra PennellSVPBuy30,000$2.43$72,900.00  
(Data available from 1/1/2013 forward)

DCTH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Delcath Systems includes Gerard J Michel, Gil Aharon, John Purpura, John Richard Sylvester, Rosalind Advisors, Inc., Sandra Pennell, Steven A J Salamon, and Vojo Vukovic. Learn more on insiders at DCTH.

17.94% of Delcath Systems stock is owned by insiders. Learn more on DCTH's insider holdings.

The following insiders have purchased DCTH shares in the last 24 months: Gerard J Michel ($195,046.64), Gil Aharon ($100,001.04), John Purpura ($49,897.20), John Richard Sylvester ($50,640.00), Rosalind Advisors, Inc. ($295,078.30), Sandra Pennell ($72,900.00), and Vojo Vukovic ($148,800.00).

Insiders have purchased a total of 310,798 DCTH shares in the last 24 months for a total of $912,363.18 bought.

Delcath Systems Key Executives

  • Mr. Gerard J. Michel MBAMr. Gerard J. Michel MBA (Age 61)
    MS, CEO & Director
    Compensation: $727.97k
  • Ms. Sandra Pennell (Age 44)
    Senior VP of Finance and Principal Financial & Accounting Officer
  • Dr. Martha S. Rook Ph.D. (Age 54)
    Chief Operating Officer
  • Mr. David Hoffman
    General Counsel, Corporate Secretary & Chief Compliance Officer
  • Dr. Johnny John M.D. (Age 59)
    Senior Vice President of Clinical Operations & Medical Affairs
    Compensation: $472.16k
  • Dr. Vojislav Vukovic M.D. (Age 57)
    M.Sc., Ph.D., Chief Medical Officer


This page (NASDAQ:DCTH) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners